Physician profile
Dean E Leocadio
NPI 1902099948
$3,243.08
in general payments reported to CMS, 2019-2025
24 companies · $49.89 in 2025
The $49.89 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $129 · 2021: $642 · 2022: $745 · 2023: $454 · 2024: $48.50 · 2025: $49.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $821.25 | 2019-2023 | Xtandi |
| Boston Scientific Corporation | $488.55 | 2019-2023 | Ams 700 Cxr Rte Kit |
| Pfizer INC. | $324.43 | 2019-2023 | |
| Neotract INC. | $218.36 | 2019 | |
| Abbvie INC. | $213.39 | 2019-2025 | |
| Teleflex LLC | $154.23 | 2021-2023 | Urolift |
| Antares Pharma, INC. | $136.95 | 2021-2023 | Nocdurna, Xyosted, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $123.39 | 2022-2023 | |
| Axonics, INC. | $122.66 | 2020-2023 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $109.26 | 2019-2021 | |
| 180 Medical, INC. | $107.24 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $104.65 | 2019-2021 | |
| Karl Storz Lithotripsy-America | $53.18 | 2019 | |
| Myovant Sciences INC. | $43.98 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $40.15 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $28.91 | 2022 | |
| Progenics Pharmaceuticals, INC. | $24.64 | 2023 | Pylarify |
| Sumitomo Pharma America, INC. | $20.92 | 2023 | Gemtesa |
| Blue Earth Diagnostics | $20.62 | 2019 | |
| Palette Life Sciences, INC. | $19.20 | 2023 | |
| Coloplast Corp | $18.35 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $18.33 | 2021 | |
| Acerus Pharmaceuticals Corporation | $16.04 | 2021 | |
| Allergan, INC. | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Leocadio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.